vs

Side-by-side financial comparison of PLAYSTUDIOS, Inc. (MYPS) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

PLAYSTUDIOS, Inc. is the larger business by last-quarter revenue ($55.4M vs $32.6M, roughly 1.7× RxSight, Inc.). PLAYSTUDIOS, Inc. runs the higher net margin — -24.7% vs -28.1%, a 3.4% gap on every dollar of revenue. On growth, PLAYSTUDIOS, Inc. posted the faster year-over-year revenue change (-18.3% vs -18.9%). PLAYSTUDIOS, Inc. produced more free cash flow last quarter ($3.6M vs $-2.3M). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs -15.6%).

PLAYSTUDIOS, Inc. develops and publishes free-to-play social and casual casino games for mobile, desktop and social platforms. It operates a loyalty rewards program that lets players redeem in-game achievements for real-world benefits including travel, dining and event tickets, serving markets across North America, Europe and Asia Pacific.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

MYPS vs RXST — Head-to-Head

Bigger by revenue
MYPS
MYPS
1.7× larger
MYPS
$55.4M
$32.6M
RXST
Growing faster (revenue YoY)
MYPS
MYPS
+0.7% gap
MYPS
-18.3%
-18.9%
RXST
Higher net margin
MYPS
MYPS
3.4% more per $
MYPS
-24.7%
-28.1%
RXST
More free cash flow
MYPS
MYPS
$5.9M more FCF
MYPS
$3.6M
$-2.3M
RXST
Faster 2-yr revenue CAGR
RXST
RXST
Annualised
RXST
5.1%
-15.6%
MYPS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MYPS
MYPS
RXST
RXST
Revenue
$55.4M
$32.6M
Net Profit
$-13.7M
$-9.2M
Gross Margin
77.5%
Operating Margin
-17.7%
-34.8%
Net Margin
-24.7%
-28.1%
Revenue YoY
-18.3%
-18.9%
Net Profit YoY
38.9%
-54.1%
EPS (diluted)
$-0.12
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MYPS
MYPS
RXST
RXST
Q4 25
$55.4M
$32.6M
Q3 25
$57.6M
$30.3M
Q2 25
$59.3M
$33.6M
Q1 25
$62.7M
$37.9M
Q4 24
$67.8M
$40.2M
Q3 24
$71.2M
$35.3M
Q2 24
$72.6M
$34.9M
Q1 24
$77.8M
$29.5M
Net Profit
MYPS
MYPS
RXST
RXST
Q4 25
$-13.7M
$-9.2M
Q3 25
$-9.1M
$-9.8M
Q2 25
$-2.9M
$-11.8M
Q1 25
$-2.9M
$-8.2M
Q4 24
$-22.4M
$-5.9M
Q3 24
$-3.1M
$-6.3M
Q2 24
$-2.6M
$-6.1M
Q1 24
$-567.0K
$-9.1M
Gross Margin
MYPS
MYPS
RXST
RXST
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
MYPS
MYPS
RXST
RXST
Q4 25
-17.7%
-34.8%
Q3 25
-13.6%
-40.1%
Q2 25
-5.9%
-41.6%
Q1 25
-4.4%
-28.2%
Q4 24
-33.1%
-21.5%
Q3 24
-6.7%
-26.1%
Q2 24
-5.5%
-23.9%
Q1 24
-2.2%
-36.2%
Net Margin
MYPS
MYPS
RXST
RXST
Q4 25
-24.7%
-28.1%
Q3 25
-15.8%
-32.4%
Q2 25
-5.0%
-35.0%
Q1 25
-4.6%
-21.6%
Q4 24
-33.1%
-14.8%
Q3 24
-4.3%
-17.9%
Q2 24
-3.6%
-17.4%
Q1 24
-0.7%
-30.8%
EPS (diluted)
MYPS
MYPS
RXST
RXST
Q4 25
$-0.12
$-0.22
Q3 25
$-0.07
$-0.24
Q2 25
$-0.02
$-0.29
Q1 25
$-0.02
$-0.20
Q4 24
$-0.18
$-0.14
Q3 24
$-0.02
$-0.16
Q2 24
$-0.02
$-0.16
Q1 24
$0.00
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MYPS
MYPS
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$104.9M
$228.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$227.9M
$275.7M
Total Assets
$290.6M
$311.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MYPS
MYPS
RXST
RXST
Q4 25
$104.9M
$228.1M
Q3 25
$106.3M
$227.5M
Q2 25
$112.9M
$227.5M
Q1 25
$107.1M
$229.3M
Q4 24
$109.2M
$237.2M
Q3 24
$105.2M
$237.1M
Q2 24
$106.3M
$233.3M
Q1 24
$127.0M
$125.4M
Stockholders' Equity
MYPS
MYPS
RXST
RXST
Q4 25
$227.9M
$275.7M
Q3 25
$238.9M
$276.0M
Q2 25
$245.3M
$278.0M
Q1 25
$244.1M
$279.3M
Q4 24
$244.7M
$281.2M
Q3 24
$265.2M
$277.3M
Q2 24
$263.6M
$275.2M
Q1 24
$288.4M
$163.9M
Total Assets
MYPS
MYPS
RXST
RXST
Q4 25
$290.6M
$311.8M
Q3 25
$299.2M
$308.5M
Q2 25
$316.2M
$309.0M
Q1 25
$313.8M
$313.0M
Q4 24
$323.0M
$318.6M
Q3 24
$330.6M
$310.5M
Q2 24
$333.4M
$305.5M
Q1 24
$357.5M
$183.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MYPS
MYPS
RXST
RXST
Operating Cash FlowLast quarter
$3.7M
$-1.1M
Free Cash FlowOCF − Capex
$3.6M
$-2.3M
FCF MarginFCF / Revenue
6.5%
-6.9%
Capex IntensityCapex / Revenue
0.2%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$25.4M
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MYPS
MYPS
RXST
RXST
Q4 25
$3.7M
$-1.1M
Q3 25
$5.7M
$-1.2M
Q2 25
$13.6M
$-4.4M
Q1 25
$3.3M
$-8.8M
Q4 24
$11.6M
$-4.3M
Q3 24
$14.6M
$650.0K
Q2 24
$14.5M
$-4.0M
Q1 24
$5.0M
$-9.3M
Free Cash Flow
MYPS
MYPS
RXST
RXST
Q4 25
$3.6M
$-2.3M
Q3 25
$5.4M
$-1.8M
Q2 25
$13.2M
$-5.9M
Q1 25
$3.2M
$-9.4M
Q4 24
$11.5M
$-5.1M
Q3 24
$13.9M
$-453.0K
Q2 24
$12.8M
$-5.5M
Q1 24
$3.6M
$-11.3M
FCF Margin
MYPS
MYPS
RXST
RXST
Q4 25
6.5%
-6.9%
Q3 25
9.3%
-5.8%
Q2 25
22.3%
-17.6%
Q1 25
5.1%
-24.8%
Q4 24
16.9%
-12.7%
Q3 24
19.6%
-1.3%
Q2 24
17.6%
-15.9%
Q1 24
4.6%
-38.2%
Capex Intensity
MYPS
MYPS
RXST
RXST
Q4 25
0.2%
3.5%
Q3 25
0.5%
1.9%
Q2 25
0.7%
4.6%
Q1 25
0.2%
1.5%
Q4 24
0.2%
2.1%
Q3 24
0.9%
3.1%
Q2 24
2.4%
4.4%
Q1 24
1.9%
6.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MYPS
MYPS

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons